References

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.

Abayomi J, Kirwan J, Hackett A, Bagnall G. A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer. J Hum Nutr Diet 2005; 18: 353-363.

Abbas A, Lichtman A, Pober J. Cellular and molecular immunology. Philadelphia, PA: WB Saunders Company, 1991.

ACOG. Cervical Cancer Screening: Testing Can Start Later and Occur Less Often Under New ACOG Recommendations. Available at: http://www.acog.org/from_home/publications/press_releases/nr07-31-03-1.cfm.

Alfsen GC, Thoresen SO, Kristensen GB, Skovlund E, Abeler VM. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer 2000; 89: 1291-1299.

American Cancer Society. All about vaginal cancer. Available at: http://www.cancer.org/docroot/CRI/CRI_2x.asp?sitearea=&dt=55. Accessed December 21, 2005a.

American Cancer Society. All about vulvar cancer. Available at: http://www.cancer.org/docroot/CRI/CRI_2x.asp?sitearea=&dt=45. Accessed December 21, 2005b.

American Cancer Society. Cancer Facts and Figures 2005. Available at: http://www.cancer.org/. Accessed October 5, 2005.

American Society of Cancer. Learn about Anal Cancer. Available at: http://www.cancer.org/docroot/LRN/LRN_0.asp?dt=47. Accessed September 15, 2005a.

American Society of Cancer. Learn about Penile Cancer. Available at: http://www.cancer.org/docroot/LRN/LRN_0.asp?dt=35. Accessed September 15, 2005b.

Anhang R, Goodman A, Goldie SJ. HPV communication: review of existing research and recommendations for patient education. CA Cancer J Clin 2004a; 54: 248-259.

Anhang R, Wright TC, Jr., Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer 2004b; 100: 315-320.

Anttila A, Pukkala E, Soderman B, Kallio M, Niemienen P, Hakama M. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer 1999; 83: 59-65.

Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System terminology.Am Fam Physician. 2003 Nov 15;68(10):1992-8

Arch Pathol Lab Med 2004; 128: 153-157.

Arnheim L. Immunological responses in genital HPV infections and etiology of cervical cancer. 2005; Doctoral dissertation.

Arrossi S, Sankaranarayanan R, Parkin DM.  Incidence and mortality of cervical cancer in Latin America. Salud pública Méx 2003; 45: 306-314.

ASCCP 2002. Available at: http://www.asccp.org/pdfs/consensus/algorithms.pdf. Accessed September 27, 2005.

ASCCP 2005a. Available at: http://www.asccp.org/edu/practice/cervix/anatomy.shtml. Accessed September 27, 2005.

ASCCP 2005b. Available at: http://www.asccp.org/edu/practice/cervix/histology.shtml. Accessed September 27, 2005.

Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA.   The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.  Psychooncology. 2003 Sep;12(6):612-9.  PMID: 12923801 [PubMed - indexed for MEDLINE]

Baker TS, Newcomb WW, Olson NH, Cowsert LM, Olson C, Brown JC. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J 1991; 60: 1445-1456.

Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 Suppl 1: S16-S24.

Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. Cervical cancer. Cancer 2003; 98: 2009-2014.

Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58: 686-699.

Bell S, Porter M, Kitchener H, Fraser C, Fisher P, Mann E. Psychological response to cervical screening. Prev Med 1995; 24: 610-616.

Bentz JS, Rowe LR, Gopez EV, Marshall CJ.  The unsatisfactory ThinPrep Pap Test: missed opportunity for disease detection? Am J Clin Pathol. 2002 Mar;117(3):457-63.  PMID: 11888086 [PubMed - indexed for MEDLINE]

Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 2002; 81: 443-450.

Bishop JW. Bigner SH. Colgan TJ. Husain M. Howell LP. McIntosh KM. Taylor DA. Sadeghi MH.   Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results.   Acta Cytologica. 42(1):189-97, 1998 Jan-Feb.

Biswas LN, Manna B, Maiti PK, Sengupta S. Sexual risk factors for cervical cancer among rural Indian women: a case-control study. Int J Epidemiol 1997; 26: 491-495.

Bjorge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315: 646-649.

Blumenthal PD, Lauterbach M, Sellors JW, Sankaranarayanan R.  Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S30-7

Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 3-13.

Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.

Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, International biological study on cervical cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.

Bouchardy C, Parkin DM, Wanner P, Khlat M. Cancer mortality among north African migrants in France. Int J Epidemiol 1996; 25: 5-13.

Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488.

Brotzman GL, Apgar BS.  Assessing colposcopic skills: the instructor's handbook.  Fam Med. 1998 May;30(5):350-5

Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005; 191: 182-192.

Bukovic D, Strinic T, Habek M, Hojsak I, Silovski H, Krhen I, Maloca I, Radan M. Sexual life after cervical carcinoma. Coll Antropol 2003; 27: 173-180.

Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16: 1-17.

Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996; 23: 333-341.

Burns JE, Maitland NJ. Human papillomaviruses and cancer. Microbiology Today 2005; 116-121.

Butler-Manuel SA, Summerville K, Ford A, Blake P, Riley AJ, Sultan AH, Monga AK, Stanton SL, Shepherd JH, Barton DP. Self-assessment of morbidity following radical hysterectomy for cervical cancer. J Obstet Gynaecol 1999; 19: 180-183.

Cancer Research UK. Cervical cancer incidence statistics for the UK. Available at: http://info.cancerresearchuk.org/cancerstats/types/cervix/incidence/. Accessed January 3, 2006.

Castellsagué X, Bosch FX, Muñoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Franceschi S. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346: 1105-1112.

Castellsagué X, Bosch FX, Muñoz N. The male role in cervical cancer. Salud Publica Mex 2003; 45 Suppl 3: S345-S353.

Castellsagué X, Muñoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; 20-28.

Chen R, Aaltonen LM, Vaheri A. Human papillomavirus type 16 in head and neck carcinogenesis. Rev Med Virol 2005.

Cheonis N. Anal neoplasia, a growing concern (2001). Available at: http://www.thebody.com/sfaf/winter01/anal.html#riskfactors. Accessed December 21, 2005.

Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, Palefsky JM. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 2005; 97: 896-905.

Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-998.

Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005b; 14: 1157-1164.

Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-105.

Condel JL, Mahood LK, Grzybicki DM, Sturgis CD, Raab SS. Papanicolaou tests diagnosed as atypical by a cytotechnologist and downgraded to benign by a pathologist: a measure of laboratory quality.  Am J Clin Pathol. 2002 Apr;117(4):534-40.

Conway K. Attitudes to Papanicolaou smears. J Psychosom Obstet Gynecol 1996; 17: 189-194.

Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E.  Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.
J Clin Pathol. 2004 Jan;57(1):68-72.  PMID: 14693839 [PubMed - indexed for MEDLINE]

Danos O, Katinka M, Yaniv M. Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae. EMBO J 1982; 1: 231-236.

Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2000; 124: 203-211.

Davidson SE, Burns MP, Routledge JA, Swindell R, Bentzen SM, West CM. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 2003; 69: 195-200.

de Jong A, van Poelgeest MI, van der Hulst JM, Drijfhout JW, Fleuren GJ, Melief CJ, Kenter G, Offringa R, van
der Burg SH. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 2004; 64: 5449-5455.

de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324: 17-27.

DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol 2003; 77: 1551-1563.

Duarte-Franco E, Franco EL. Cancer of the Uterine Cervix. BMC Womens Health 2004; 4 Suppl 1: S13.

Duttagupta C, Sengupta S, Roy M, Sengupta D, Bhattacharya P, Laikangbam P, Roy S, Ghosh S, Das R. Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Int J Gynecol Cancer 2004; 14: 293-303.

Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 1997; 71: 2449-2456.

Ferlay J, Bray P, Pizani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 5, Version 2.0 IARCPress, Lyon, 2004 Available at: http://www-dep.iarc.fr/ Accessed September 20, 2005.

Franceschi S. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res 2005; 166: 277-297.

Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001; 164: 1017-1025.

French DP, Maissi E, Marteau TM. Psychological costs of inadequate cervical smear test results. Br J Cancer 2004; 91: 1887-1892.

Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, Goldman S, Svensson C, Adami HO, Melbye M. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-1358.

Gagne SE, Jensen R, Polvi A, Costa MD, Ginzinger D, Efird JT, Holly EA, Darragh T, Palefsky JM. High-Resolution Analysis of Genomic Alterations and Human Papillomavirus Integration in Anal Intraepithelial Neoplasia. J Acquir Immune Defic Syndr 2005; 40: 182-189.

Gall SA. Female genital warts: global trends and treatments. Infect Dis Obstet Gynecol 2001; 9: 149-154.

Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M. Human papillomavirus infection requires cell surface heparan sulfate. J Virol 2001; 75: 1565-1570.

Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis 2002; 186: 462-469.

Giuliano AR, Papenfuss M, Abrahamsen M, Denman C, de Zapien JG, Henze JL, Ortega L, Brown de Galaz EM, Stephan J, Feng J, Baldwin S, Garcia F, Hatch K. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001; 10: 1129-1136.

Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer 2003; 106: 896-904.

Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004; 96: 604-615.

Gonçalves MA, Donadi EA. Immune cellular response to HPV: current concepts. Braz J Infect Dis 2004; 8: 1-9.

Gravitt PE, Jamshidi R. Diagnosis and management of oncogenic cervical human papillomavirus infection. Infect Dis Clin North Am 2005; 19: 439-458.

Grainge MJ, Seth R, Guo L, Neal KR, Coupland C, Vryenhoef P, Johnson J, Jenkins D. Cervical human papillomavirus screening among older women. Emerg Infect Dis. 2005 Nov;11(11):1680-5

Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E. Prospective assessment of quality of life of female cancer patients. Gynecol Oncol 2002; 85: 140-147.

Greimel ER, Bottomley A. Quality of life issues in gynecological cancer. Expert Review of Pharmaceconomics and Outcomes Research 2001; 1: 93-98.

Greimel ER, Freidl W. Functioning in daily living and psychological well-being of female cancer patients. J Psychosom Obstet Gynaecol 2000; 21: 25-30.

de Groot JM, Mah K, Fyles A, Winton S, Greenwood S, Depetrillo AD, Devins GM.  The psychosocial impact of cervical cancer among affected women and their partners. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):918-25. PMID: 16174246 [PubMed - indexed for MEDLINE]

Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, Williams C, Collingwood M.  Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.  Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002225. Review. PMID: 16034873 [PubMed - indexed for MEDLINE]

Gross G, Ikenberg H, Gissmann L, Hagedorn M. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol 1985; 85: 147-152.

Gunzer M, Weishaupt C, Hillmer A, Basoglu Y, Friedl P, Dittmar KE, Kolanus W, Varga G, Grabbe S. A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo. Blood 2004; 104: 2801-2809.

Hack TF, Degner LF, Watson P, Sinha L. Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psychooncology 2006; 15: 9-19.

Halbert CL, Demers GW, Galloway DA. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol 1992; 66: 2125-2134.

Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G. Efficacy of a bivalent L1 virus-like
particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364: 1757-1765.

Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, Strickler HD. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005; 293: 1471-1476.

Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, Schmidt M, Pilch H, Schoenefuss G, Knapstein PG, Koelbl H, Kelleher DK, Vaupel P. The impact of treatment for genital cancer on quality of life and body image--results of a prospective longitudinal 10-year study. Gynecol Oncol 2004; 94: 398-403.

Hellberg D, Stendahl U. The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer. Anticancer Res 2005; 25: 3041-3046.

Hernandez BY. Molecular epidemiology and natural history of human papillomavirus infection in heterosexual men. Available at: http://www.hawaii.edu/pceidr/research.htm. Accessed September 13, 2005.

Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 464-474.

Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez AC, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001; 93: 315-318.

Hillard PA, Biro FM, Wildey L.  Complications of cervical cryotherapy in adolescents. J Reprod Med. 1991 Oct;36(10):711-6. Review. PMID: 1956010 [PubMed - indexed for MEDLINE]

Hinkula M, Pukkala E, Kyyronen P, L, kkanen P, K, kela P, P, vonen J, L, tinen M, K, ppila A. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Br J Cancer 2004; 90: 1025-1029.

Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428.

Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999; 91: 252-258.

Hoyer H, Scheungraber C, Kuehne-Heid R, Teller K, Greinke C, Leistritz S, Ludwig B, Durst M, Schneider A.
 Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting. Int J Cancer. 2005 Aug 10;116(1):136-43. PMID: 15756677 [PubMed - indexed for MEDLINE]

IARC. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginner's manual. Available at: http://screening.iarc.fr/colpochap.php?lang=1&chap=1.

Insinga RP, Glass AG, Rush BB.  The health care costs of cervical human papillomavirus--related disease.
Am J Obstet Gynecol. 2004 Jul;191(1):114-20. PMID: 15295351 [PubMed - indexed for MEDLINE]

Jackson AP, Charleston MA. A cophylogenetic perspective of RNA-virus evolution. Mol Biol Evol 2004; 21: 45-57.

Jacob M, Broekhuizen FF, Castro W, Sellors J. Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings. Int J Gynaecol Obstet 2005; 89 Suppl 2: S13-S20.

Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2003; 56: 937-949.

Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psychooncology 2003; 12: 267-279.

Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N.  Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess. 2004 May;8(20):iii, 1-78. Review. PMID: 15147611 [PubMed - indexed for MEDLINE]

Khanna N, Phillips MD. Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions. J Am Board Fam Pract 2001; 14: 123-130.

King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003; 1: 116.

Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of principle Study Investigators.  A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002 Nov 21;347(21):1645-51. PMID: 12444178 [PubMed - indexed for MEDLINE]

Lee JH, Smith RJ. Recurrent respiratory papillomatosis: pathogenesis to treatment. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 354-359.

Lehtinen M, Paavonen J. Vaccination against human papillomaviruses shows great promise. Lancet 2004; 364: 1731-1732.

Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991; 165: 658-662.

Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005; 97: 675-683.

Liu S, Semenciw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 2001; 164: 1151-1152.

Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004; 68: 362-372.

Luxton J, Shepherd P. Human papillomavirus antigens and T-cell recognition. Curr Opin Infect Dis 2001; 14: 139-143.

Maalej M, Mrad K, Kochbati L, Guigua A, Ben Abdallah M, Ben Ayed F, Ben Romdhane K. Cervical cancer in Tunisia: an epidemiological, clinical and pathological study. Eur J Obstet Gynecol Reprod Biol 2004; 113: 226-228.

Mahar F, Sherrard J. Sexually transmitted infections. In: Rees M, Mander T, eds. Sexual health and the menopause. The Royal Society of Medicine, 2005: 55-62.

Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst 2002; 94: 1469-1483.

Marieb E. Essentials of human anatomy and physiology. 8th edition. San Francisco: Pearson Benjamin Cummings, 2005.

Mayrand MH, Coutlee F, Hankins C, Lapointe N, Forest P, de Ladurantaye M, Roger M. Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol 2000; 38: 3388-3393.

McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J.  Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK.
Br J Cancer. 2003 Jan 13;88(1):42-6.  PMID: 12556957 [PubMed - indexed for MEDLINE]

McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004; 111: 1437-1443.

McIntosh N. Human papillomavirus and cervical cancer. Available at: http://www.jhpiego.org/scripts/pubs/category_detail.asp?category_id=4. Accessed September 20, 2005.

Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer 1995; 71: 894-897.

Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87: 324-333.

Monk BJ, Huang HQ, Cella D, Long HJ 3rd; Gynecologic Oncology Group Study.  Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol. 2005 Jul 20;23(21):4617-25. Epub 2005 May 23. Erratum in: J Clin Oncol. 2005 Nov 20;23(33):8549. PMID: 15911864 [PubMed - indexed for MEDLINE]

Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132: 277-284.

Motoyama S, Ladines-Llave CA, Luis VS, Maruo T. The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe J Med Sci 2004; 50: 9-19.

Münger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78: 11451-11460.

Münger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 213-228.

Muñoz N, Bosch FX, Castellsagué X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJLM. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-285.

Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.

Myint S. Viruses. Available at: http://www.tulane.edu/~dmsander/WWW/MBChB/7.html. Accessed November 25, 2005.

National Cancer Institute. Screeing for cervical cancer. Available at: http://www.meb.uni-bonn.de/cancer.gov/CDR0000062756.html. Accessed November 25, 2005.

NHS Cervical Screening Programme. Available at: http://www.cancerscreening.nhs.uk/cervical/#eligible.

Nicol AF, Fernandes AT, Bonecini-Almeida MG. Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review. Mem Inst Oswaldo Cruz 2005; 100: 1-12.

Nossal GJ. Life, death and the immune system. Sci Am 1993; 269: 52-62.

O'Brien PM, Saveria Campo M. Papillomaviruses: a correlation between immune evasion and oncogenicity? Trends Microbiol 2003; 11: 300-305.

Östör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-192.

Palefsky JM, Holly EA. Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003; 41-46.

Palmer AG, Tucker S, Warren R, Adams M. Understanding women's responses to treatment for cervical intra-epithelial neoplasia. Br J Clin Psychol 1993; 32 ( Pt 1): 101-112.

Patnick J. Cervical cancer screening in England. Eur J Cancer 2000; 36: 2205-2208.

Pearman T. Quality of life and psychosocial adjustment in gynecologic cancer survivors. Health Qual Life Outcomes 2003; 1: 33.

Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, Haywood M, Elanko N, Coleman D, Yule R, Desai M.
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.
Br J Cancer. 2004 Aug 31;91(5):942-53.  PMID: 15292939 [PubMed - indexed for MEDLINE]

Pow-Sang MR, Benavente V, Pow-Sang JE, Morante C, Meza L, Baker M, Pow-Sang JM. Cancer of the penis. Cancer Control 2002; 9: 305-314.

Prendiville W, Davies P. Human papillomavirus and genital warts: relationship and management. In: Prendiville W, Davies P, eds. The Health Professionals HPV Handbook: Human Papillomavirus and Cervical Cancer. Oxford: Taylor and Francis, 2004a: 27-40.

Prendiville W, Davies P. The Human Papillomavirus. In: Prendiville W, Davis P, eds. The Health Professionals HPV Handbook: Human papillomavirus and cervical cancer. Oxford: Taylor and Francis, 2004b: 11-26.

Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999; 318: 904-908.

Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ.  Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV.  Diagn Cytopathol. 2003 Sep;29(3):149-55

Raven P, Johnson G, Losos J, Singer S. Biology. 7th edition. Boston: McGraw Hill, 2002.

Renshaw AA, Mody DR, Lozano RL, Volk EE, Walsh MK, Davey DD, Birdsong GG. Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: comparison of diagnostic accuracy with other high-grade lesions.
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 1975-2000. Available at: http://seer.cancer.gov/csr/1975_2000/.

Rodriguez MA, Ward LM, Perez-Stable EJ. Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med 2005; 3: 235-241.

Roitt IM, Delves PJ. Essential immunology. 10th edition. Malden, MA: Blackwell Science, 2001.

Salazar EL, Mercado E, Calzada L. Human papillomavirus hpv-16 DNA as an epitheliotropic virus that induces hyperproliferation in squamous penile tissue. Arch Androl 2005; 51: 327-334.

Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001; 79: 954-962.

Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 2005; 89 Suppl 2: S4-S12.

Sapp M, Volpers C, Muller M, Streeck RE. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. J Gen Virol 1995; 76 (Pt 9): 2407-2412.

Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 1996; 73: 1001-1005.

Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 2003; 349: 1501-1509.

Schiffman M, Kjaer SK.  Chapter 2: Natural history of anogenital human papillomavirus infection and
neoplasia. J Natl Cancer Inst Monogr. 2003;(31):14-9. Review. PMID: 12807940 [PubMed - indexed for MEDLINE]

Schiffman M, Solomon D. Arch Pathol Lab Med. 2003 Aug;127(8):946-9.  Findings to date from the ASCUS-LSIL Triage Study (ALTS).

Schiller JT, Davies P. Delivering on the promise: HPV vaccines and cervical cancer. Nat Rev Microbiol 2004; 2: 343-347.

SEER Cancer Statistics Review. Available at: http://seer.cancer.gov/.

SEER Cancer Statistics Review. Available http://seer.cancer.gov/.
September 20, 2005.

SGOC. Programmatic Guidlines for Screening for Cancer of the  Cervix in Canada. 1998;  1-36.

Sheets EE. Management of adenocarcinoma in situ, micro-invasive, and early stage adenocarcinoma of the cervix. Curr Opin Obstet Gynecol 2002; 14: 53-57.

Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 2005; 103: 1258-1264.

Smith EM, Johnson SR, Ritchie JM, Feddersen D, Wang D, Turek LP, Haugen TH. Persistent HPV infection in postmenopausal age women. Int J Gynaecol Obstet 2004; 87: 131-137.

Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. Gynecol Oncol 2000; 78: 97-105.

Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-299.

Southern Illinois University School of Medicine. Epithelium study guide. Available at: http://www.siumed.edu/~dking2/intro/epith.htm. Accessed November 28, 2005.

Stanley M. Immune responses to human papillomavirus. Vaccine 2005.

Stuart GC, McGregor SE, Duggan MA, Nation JG. Review of the screening history of Alberta women with invasive cervical cancer. CMAJ 1997; 157: 513-519.

Szarewski A, Sasieni P. Cervical screening in adolescents--at least do no harm. Lancet 2004; 364: 1642-1644.

Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis 2004; 10: 1915-1923.

Taylor LA, Sorensen SV, Ray NF, Halpern MT, Harper DM. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors. Arch Fam Med 2000; 9: 713-721.

Thompson DL, Douglas JM, Jr., Foster M, Hagensee ME, Diguiseppi C, Barón AE, Cameron JE, Spencer TC, Zenilman J, Malotte CK, Bolan G, Kamb ML, Peterman TA, for the Project RESPECT Study Group. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis 2004; 190: 1563-1574.

UK Government Statistical Services. NHS Cervical Screening Programme Statistics. Available at: http://www.cancerscreening.nhs.uk/cervical/#cost. Accessed September 20, 2005.

Unger ER, Barr E. Human papillomavirus and cervical cancer [conference summary]. Available at: Emerging Infect Dis [serial on the Internet (http://www.cdc.gov/ncidod/EID/vol10no11/04-0623_09.htm)]. Accessed February 1, 2006.

Vallabhan S. American Cancer Society regional initiatives. Available at: http://www.cancer.org/docroot/AA/content/AA_2_5_8x_India.asp?sitearea=AA. Accessed

van der Graaf Y, Vooijs GP, Gaillard HL, Go DM. Screening errors in cervical cytologic screening. Acta Cytol. 1987 Jul-Aug;31(4):434-8

van Leeuwen AW, de Nooijer P, Hop WC. Screening for cervical carcinoma. Cancer 2005; 105: 270-276.

Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E.
 Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005 May;6(5):271-8. PMID: 15863374 [PubMed - indexed for MEDLINE]

Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol 1997; 4: 122-126.

Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Borras J, Parkin DM. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000; 86: 429-435.

Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998; 75: 536-545.

von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001; 11: 598-603.

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.

Waller J, McCaffery K, Nazroo J, Wardle J. Making sense of information about HPV in cervical screening: a qualitative study. Br J Cancer 2005; 92: 265-270.

Wentzensen N, Vinokurova S, von Knebel DM. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004; 64: 3878-3884.

Wenzel L, DeAlba I, Habbal R, Kluhsman BC, Fairclough D, Krebs LU, Anton-Culver H, Berkowitz R, Aziz N. Quality of life in long-term cervical cancer survivors. Gynecol Oncol 2005; 97: 310-317.

Wilson FX. Emerging therapies for human papillomavirus infection. Expert Opin Emerg Drugs 2001; 6: 199-207.

Wright TC Jr  Chapter 10: Cervical cancer screening using visualization techniques. J Natl Cancer Inst Monogr. 2003;(31):66-71

Wolstenholme JL, Whynes DK. Stage-specific treatment costs for cervical cancer in the United Kingdom. Eur J Cancer 1998; 34: 1889-1893.

Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 2004; 109: 418-424.

Zola P, Magistris A, Landoni F, Sartori E, Maggino T, Gadducci A, Fuso L, Peroglio CA, Ferrero A, Jacomuzzi ME. The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study. Crit Rev Oncol Hematol 2003; 48: 317-321.